A new study found that one-quarter of medical students are so disenchanted with their program they are considering quitting. A much larger proportion of medical students and nursing students (58%) would prefer a career in health care where they don’t treat patients. Students were especially worried about the cost of their education, but also burdened by the…
Category: Doctors & Hospitals
Wednesday Links
- Study: The global COVID-19 campaign vaccinated over 2 billion people within the first 8 months. We find that the vaccination campaign across 141 countries averted 2.4 million excess deaths, valued at $6.5 trillion.
- Burnout among health care workers: Less than 30 percent are “very happy”; more than a third report symptoms of “depression”; more than half have symptoms of “anxiety.”
- Who makes more money from the sale of generic drugs – PBMs or drug manufacturers?
- How many prescription drugs do people take over their lifetimes? non-Hispanic Whites take the most, Hispanics take the least, and non-Hispanic Blacks fall in between these extremes.
Tuesday Links
- Misinformation Update: One of the strangest aspects of the Covid pandemic was the early insistence by the WHO and the CDC that COVID was not airborne.
- Good news: since before the pandemic, Americans’ wealth is way up, and inequality is down.
- A positive view of doctor assisted suicide. (NYT)
- 55 percent of E.R. doctors say they have been physically assaulted, almost all by patients.
- New test says it can find cancer for $949. Why do some doctors think that is not a good idea? (WSJ)
Monday Links
- Who delays care because of cost? Only 29% with employer coverage; 37% with Obamacare; 39% with Medicaid and 42% with Medicare.
- Given an average waiting time of 2½ hours before being discharged, how can there be too many emergency care physicians?
- The “surprise billing” solution isn’t working: Only 4% of the roughly 90,000 payment disputes initiated between April and September have been resolved.
- A CMS rule change will lead to $700 million less savings than the CBO estimated when evaluating the act that allows Medicare to negotiate drug prices.